Articles tagged "Liver transplantation"

2019 American Transplant Congress
Early Achievement of Sustained Virological Response in Liver Transplant Recipients with Hepatitis C Reduces Risks of End Stage Renal Disease
M. Yoshikawa¹, T. Fukumoto²
¹Nephrology, Kobe University Hospital, Kobe, Japan, ²Hepato-Biliary-Pancreas Surgery, Kobe University Hospital, Kobe, Japan
*Purpose: Chronic kidney disease (CKD) is common after liver transplantation (LT) and result worse morbidity and mortality. Hepatitis C virus (HCV) infection is recognized as…
2019 American Transplant Congress
Orthotopic Liver Transplantation in MPV17 Deficiency: A Case Series
E. A. Gerzina¹, E. D. Witte¹, M. L. Kueht², R. W. Himes³
¹Baylor College of Medicine, Houston, TX, ²Department of Surgery, Division of Abdominal Transplant, Baylor College of Medicine, Houston, TX, ³Pediatrics--Gastroenterology, Baylor College of Medicine, Houston, TX
*Purpose: The purpose of this study was to consider the clinical courses of two patients with MPV17 mutations and to evaluate the efficacy of liver…
2019 American Transplant Congress
HuR Dictates HO-1 Expression, Modulates Inflammation and Influences Recipient Outcomes in Liver Transplant Patients
K. J. Dery, K. Nakamura, K. Kadono, H. Hirao, S. Kageyama, T. Ito, J. Aziz, B. Ke, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski
Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA
*Purpose: Liver ischemia-reperfusion injury, an innate-immune dominated hepatocellular damage, is a risk factor of early graft dysfunction and rejection in liver transplantation (LT). HuR, an…
2019 American Transplant Congress
Management of Dyslipidemia after Liver Transplantation
S. S. Patel¹, V. A. Rodriguez², M. B. Siddiqui¹, M. Faridnia³, F. Lin⁴, J. Laurenzano⁴, J. Clinton⁴, A. Chandrakumaran³, T. Reichman⁵, C. Bhati⁵, M. S. Siddiqui¹
¹Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, ²Department of Bio-statistics, Virginia Commonwealth University, Richmond, VA, ³Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, ⁴Virginia Commonwealth University, Richmond, VA, ⁵Department of Transplant Surgery, Virginia Commonwealth University, Richmond, VA
*Purpose: Cardiovascular disease (CVD) remains a major cause of long-term mortality in liver transplant recipients (LTR). Adequate control of CVD risk factors like hypertension, diabetes,…
2019 American Transplant Congress
Novel Cell-Free and Concentrated Ascites Reinfusion Therapy for Management of Refractory Ascites in Liver Transplant Candidates
K. Sato, M. Ohira, Y. Imaoka, S. Hashinoto, H. Tahara, K. Ide, T. Kobayashi, Y. Tanaka, H. Ohdan
Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan
*Purpose: Refractory ascites at perioperative period in liver transplantation (LT) is associated with the increased morbidity and mortality. The aim of this study is to…
2019 American Transplant Congress
Geographic Disparities in Liver Supply/Demand Ratio within Fixed-Distance and Fixed-Person Circles
C. Haugen¹, T. Ishaque¹, A. Sapirstein¹, D. Segev¹, S. Gentry²
¹JHU, Baltimore, MD, ²USNA, Baltimore, MD
*Purpose: Geographic disparity in deceased donor liver allocation has been extensively documented. Many stakeholders believe allocating within circular fixed-distance or fixed-person boundaries would reduce geographic…
2019 American Transplant Congress
Repeat Liver Transplantation after Failed First Transplant in Childhood: Development of a Retransplant Risk Index
M. Gupta¹, M. Barry², M. Levine³, K. Olthoff³, A. Shaked³, P. Abt³
¹University of Kentucky, Lexington, KY, ²University of California, San Francisco, San Francisco, CA, ³University of Pennsylvania, Philadelphia, PA
*Purpose: Most morbidity and mortality after pediatric liver retransplantation (LRTx) occurs in the first 100 days. We studied factors associated with mortality and graft failure…
2019 American Transplant Congress
QA of MMR/VZV Protocol-Driven Serologic Screening and Infectious Disease Consultation (IDC) Are Strongly Recommended in Heart, Lung, Liver (HLL) SOTs
Z. Seckin, L. Brumble, C. Libertin
Mayo Clinic, Jacksonville, FL
*Purpose: SOT recipients are at risk of acquiring life-threatening infections putting their graft and life at risk. Prevention, including immunization with live virus vaccines pre-transplantation…
2019 American Transplant Congress
Assessing the Effectiveness of Early Maintenance Immunosuppression Practices in Liver Transplantation
T. Bittermann, R. Hubbard, J. Lewis, D. Goldberg
University of Pennsylvania, Philadelphia, PA
*Purpose: Evidence regarding the efficacy of maintenance immunosuppression (IS) regimens for liver transplantation (LT) arise from clinical trials. However, the ‘real world’ effectiveness of such…
2019 American Transplant Congress
Assessing Discarded Human Liver Quality with Normothermic Ex-Vivo Liver Perfusion
F. Zhou, M. Xu, S. Garcia-Aroz, G. A. Upadhya, Y. Lin, W. C. Chapman
Surgery, Washington University in St. Louis, St. Louis, MO
*Purpose: Normothermic Ex-vivo Liver Perfusion (NELP) of livers shows promising results in overcoming injuries that occur in deceased donor liver transplantation. The effect of NELP…